Is artificial intelligence the silver bullet for preventing blindness, or are we missing the “last mile” of patient care?
In this episode of AI Innovators, Rehan Ahmed, MD, sits down with Roomasa Channa, MD, a retina specialist and the co-director of the AI unit at the University of Wisconsin-Madison, to peel back the curtain on the real-world impact of autonomous technology in ophthalmology.
Why You Need to Listen:
- The Unfiltered Truth on Adoption: Despite FDA-approved algorithms and dedicated billing codes, why is the actual uptake of AI screening for diabetic retinopathy still less than 1% for at-risk patients? Dr. Channa breaks down the “implementation science” needed to move beyond the tech.
- The Follow-Up Paradox: Dr. Channa reveals a shocking simulation result: 100% screening doesn’t automatically mean 100% vision saved. Learn about the “AI Bridge” program designed to ensure patients don’t just get a diagnosis, but actually receive treatment.
- The Future of the “Pan-Algorithm:” Are we moving toward a future where one AI can detect everything from glaucoma to AMD in a single scan? Explore how Large Language Models (LLMs) might soon provide human-like interpretations that build doctor and patient trust.
- AI in the Optical Shop: Discover why your local retail eyecare setting or optical shop might be the most critical battleground for mass eye screening in America.
Watch or listen to the full discussion here:
Catch up on the whole AI Innovators series here
Author
